Published ahead of print on March 3, 2005, doi:10.1165/rcmb.2005-0059OC
American Journal of Respiratory Cell and Molecular Biology. Vol. 32, pp. 548-552, 2005
© 2005 American Thoracic Society DOI: 10.1165/rcmb.2005-0059OC
Lysozyme Secretion by Submucosal Glands Protects the Airway from Bacterial Infection
Rana Dajani,
Yulong Zhang,
Peter J. Taft,
Sue M. Travis,
Timothy D. Starner,
Ansgar Olsen,
Joseph Zabner,
Michael J. Welsh and
John F. Engelhardt
Department of Anatomy and Cell Biology, Department of Internal Medicine, Department of Microbiology, Center for Gene Therapy, and Howard Hughes Medical Institute, University of Iowa, Iowa City, Iowa
Correspondence and requests for reprints should be addressed to John F. Engelhardt, Department of Anatomy and Cell Biology, University of Iowa, Room 1-111 Bowen Science Building, 51 Newton Road, Iowa City, IA 52242-1109. E-mail: john-engelhardt{at}uiowa.edu
Submucosal glands are abundant ( 1 gland/mm2) secretory structures in the tracheobronchial airways of the human lung. Because submucosal glands express antibacterial proteins, it has been proposed that they contribute to lung defense. However, this concept is challenged by the fact that mice do not have submucosal glands in their bronchial airways, yet are quite resistant to bacterial lung infection. The contribution of airway submucosal glands to host defense is also debated as a pathophysiologic component of cystic fibrosis lung disease. Here, we asked whether submucosal glands protect airways against bacterial infection. By comparing tracheal xenograft airways with and without glands, we found that the presence of glands enhanced bacterial killing in vivo and by airway secretions in vitro. Moreover, immunodepletion studies suggested that lysozyme is a major antibacterial component secreted by submucosal glands. These studies provide evidence that submucosal glands are a major source of antibacterials critical for maintaining sterile airways.
Key Words: innate immunity lung lysozyme glands antibacterial proteins
This article has been cited by other articles:

|
 |

|
 |
 
P. Moskwa, D. Lorentzen, K. J. D. A. Excoffon, J. Zabner, P. B. McCray Jr., W. M. Nauseef, C. Dupuy, and B. Banfi
A Novel Host Defense System of Airways Is Defective in Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
January 15, 2007;
175(2):
174 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Wu, M. E. Krouse, and J. J. Wine
Acinar origin of CFTR-dependent airway submucosal gland fluid secretion
Am J Physiol Lung Cell Mol Physiol,
January 1, 2007;
292(1):
L304 - L311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Nash, T. N. S. Ballard, T. E. Weaver, and H. T. Akinbi
The Peptidoglycan-Degrading Property of Lysozyme Is Not Required for Bactericidal Activity In Vivo
J. Immunol.,
July 1, 2006;
177(1):
519 - 526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Cantin, J. W. Hanrahan, G. Bilodeau, L. Ellis, A. Dupuis, J. Liao, J. Zielenski, and P. Durie
Cystic Fibrosis Transmembrane Conductance Regulator Function Is Suppressed in Cigarette Smokers
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1139 - 1144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Wine
Acid in the airways. Focus on "Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis"
Am J Physiol Cell Physiol,
March 1, 2006;
290(3):
C669 - C671.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society.
|
|
|